The Lollipop War Has Begun
Podcast |
MarketFoolery
Publisher |
The Motley Fool
Media Type |
audio
Categories Via RSS |
Business
Business News
News
Publication Date |
Mar 21, 2019
Episode Duration |
00:17:51

Biogen falls 30% after halting trials for its Alzheimer’s drug. Healthcare analyst (and Industry Focus host) Shannon Jones discusses potential next moves for the suddenly-embattled pharmaceutical company. CVS starts selling cannabis products in eight states. Plus, a federal judge sides with the maker of Dum Dum lollipops in a battle against Tootsie Roll.

Get $50 off your first job post at www.LinkedIn.com/Fool.

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review